# Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients

> **NCT01721434** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Medical Center Nijmegen** · enrollment: 42 (estimated)

## Conditions studied

- Muscle Weakness Conditions
- Weaning Failure

## Interventions

- **DRUG:** Levosimendan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01721434
- **Lead sponsor:** University Medical Center Nijmegen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2015-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721434, "Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT01721434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*